IntriCon — Investor Presentation (January 2008)
23 slides from IntriCon's investor presentation, Jan 17, 2008
Slide 1: IntriCon: The Body-Worn Device Company
° fntriCon e The Body-Worn Device Company
Slide 2: Safe Harbor Statement
Forward-looking statements contained in this presentation are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. The statements can be identified by words such as “may,” “will,” “expect,” “believe,” “anticipate,” “estimate,” “continue” or other simil
Slide 3: Company Information
NASDAQ: “IIN”; Founded in 1977 625 employees Proprietary firmware that enhances performance of body-worn devices Expertise in ultra-miniature mechanics & electronics International presence $60+ million revenue; profitable Company Information
Slide 4: Our Mission
IntriCon’s mission is to enhance the mobility & effectiveness of body-worn devices that connect people to people & to the devices around them. Our Mission
Slide 5: Body-worn Devices
Ear-Worn Head Sets Ear-Worn Mics Wireless Push-To- Talk Radio Adapter Wireless Glucose Sensor Digital Hearing Aids Drug Delivery Sets Body-worn Devices IV Delivery Sets Future – Medical Biotelemetry (EKG, EEG, etc.) ---- Established Core Business ---- Emerging Core Business
Slide 6: Profit Drivers
Premium pricing power through application of digital firmware (e.g., “Intel Inside”) & wireless technology to our established core business Actively pursuing appropriate M&A opportunities to build our leadership position in body-worn devices (e.g., Tibbetts) Maximizing R&D spending to expand establi
Slide 7: Proprietary Technology: Hearing Instrument Assemblies
Proprietary Technology Hearing Instrument Assemblies
Slide 8: Proprietary technology (firmware) means high-value, body-wearable features
Proprietary technology (firmware) means high-value, body- wearable features Hearing & professional audio & security Adaptive feedback canceling Directional microphone arrays Active noise canceling Voice feature extraction Noise reduction Emerging Medical Biotelemetry Proprietary Technology Ultra-Low
Slide 9: Proprietary Technology: Ultra-Low-Power Wireless
Proprietary Technology Ultra-Low-Power Wireless Performance comparison to Bluetooth: Allows miniaturization 25 times lower power consumption Lower power supply voltage Ultra-low-power wireless is superior in critical applications: Hearing Professional Audio Security Medical Biotelemetry
Slide 10: Company Evolution
Founded as RTI - 1977 Acquired by Selas - 1993 Mark Gorder Appointed CEO - 2001 Purchased Lectret - 2001 AMIS Strategic Alliance - 2003 (DSP & ULP) Sale of Non-Strategic Assets - 2001-2005 Rebranded as IntriCon (IIN) - 2005 Company Evolution Acquired Tibbetts - 2007
Slide 11: Experienced Management Team
Mark Gorder President, CEO & Founder Scott Longval CFO, Secretary & Treasurer Chris Conger VP of Research & Development Mike Geraci VP of Sales & Marketing Dennis Gonsior VP of Global Operations Greg Gruenhagen VP of Quality & Regulatory Affairs Steve Binnix VP of RTI Electronics . . . combined 135
Slide 12: International Presence
Arden Hills, MN (HQ) Vadnais Heights, MN Singapore Camden, ME Munich, Germany Anaheim, CA Established Presence & Low-cost Manufacturing International Presence
Slide 13: Experienced Corporate Governance
Experienced Corporate Governance Michael J. McKenna Chairman of the Board Retired Vice Chairman, President and Director, Crown Cork & Seal Company, Inc. Nicholas A. Giordano Chairman of the Audit Committee Business Consultant Former President & CEO, Philadelphia Stock Exchange Robert N. Masucci Dire
Slide 14: Growth Drivers: Body-Worn Devices
Over-65 age group fastest growing segment in U.S., Europe & Japan Increased spending on security, intelligence & defense Wireless becoming connectivity standard Telemedicine using wireless miniature biosensors Demand for quality Growth Drivers: Body-Worn Devices
Slide 15: Revenues
Revenues (in millions) For the nine-months ending September 30, 2007 revenue increased 33% over same prior-year period (organic growth of 26%)
Slide 16: Income From Continuing Operations
For the nine-months ending September 30, 2007 income from continuing operations increased $443K, or 58%, over prior-year period 2007 YTD results include $110K prepayment penalty & $65K deferred financing write- off related to May refinancing Income From Continuing Operations (in millions)
Slide 17: EPS From Continuing Operations
For the nine-months ending September 30, 2007 EPS from continuing operations increased to $0.22, or 57%, over year-ago period (includes $0.03 charge relating to debt refinancing) EPS From Continuing Operations
Slide 18: Balance Sheet
$10,655 $ 8,445 $17,038 $15,607 Balance Sheet Q3 2007 Cash $ 1,092 $ 660 Working capital Total debt $ 9,968 $ 4,783 Shareholders’ equity Cash cycle days of 70 Working capital continues to increase to support revenue growth $10.0M of debt - $5.5M revolver, $4.4M long-term note, $0.1M capital leases (
Slide 19: Cash Flow
$ (6,362) $ (565) $ 31 $ 45 Cash Flow Q3YTD Full Year Net cash provided by operating activities $ 870 $ 1,578 Net cash used by investing activities Net cash provided (used) by financial activities $ 5,884 $ (1,568) Effect of exchange rate changes on cash Net increase (decrease) in cash $ 423 $ (510)
Slide 20: Prepared for Continued Growth
New credit facility Strategic acquisition of Tibbetts Singapore & Minnesota facilities expanding Biotelemetry opportunities Prepared for Continued Growth
Slide 21: Financial Goals
While our business can fluctuate quarter-to-quarter, we are targeting low double-digit revenue growth in 2008 Our goal is to improve gross margins from 25 percent to 30 percent by 2012 While we intend to prudently control operating expenses, we are committed to increase R&D as a percentage of sales
Slide 22: Why IntriCon?
Why IntriCon? Leader in high-performance body-worn devices Increasing market opportunity for body-worn devices Proprietary technology is well positioned for future market opportunities Real markets - Realistic goals
Slide 23: IntriCon: The Body-Worn Device Company
° fntriCon e The Body-Worn Device Company